Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide (LY3437943), developed by Eli Lilly, is a once-weekly injectable GIP/GLP-1/glucagon triple receptor agonist
Description Melanotan 2 (MT-2) Research Peptide (10 mg) Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analogue of endogenous -melanocyte-stimulating hormone (-MSH), developed at the University of Arizona as a structurally minimized, conformationally constrained derivative designed to improve metabolic stability and receptor selectivity relative to the native hormone and its linear analogue Melanotan 1
Folic acid supplementation improves glycemic control for diabetes prevention and management: a systematic review and dose-response meta-analysis of randomized controlled trials
What Does U-100 Mean on a Syringe
US$ 26.20
US$ 20.79
US$ 21.30
US$ 21.42
US$ 25.16
US$ 24.41
